Presenter: Dr. Marilyn Huestis
Dr. Marilyn A. Huestis recently retired as a tenured senior investigator and Chief, Chemistry and Drug Metabolism Section, IRP, National Institute on Drug Abuse, National Institutes of Health, after 23 years of conducting controlled drug administration studies. She was also an Adjunct Professor at the University of Maryland School of Medicine, Baltimore, MD until 2017.
Currently, she is Senior Fellow, Institute on Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, serves on the Smart Approaches to Marijuana (SAM) Science Advisory Board, Senior Scientific Advisor of NMS Labs, Consultant to the US Department of Transportation, and is President of Huestis & Smith Toxicology, LLC.
Her research program focused on discovering mechanisms of action of cannabinoid agonists and antagonists, effects of in utero drug exposure, oral fluid testing, driving under the influence of drugs, and the neurobiology and pharmacokinetics of novel psychoactive substances. Professor Huestis’ research also explored new medication targets for cannabis dependence, including oral tetrahydrocannabinol (THC), Sativex, a 1:1 ratio of tetrahydrocannabinol and cannabidiol.
